147 related articles for article (PubMed ID: 34245919)
1. HDAC1-Dependent Repression of Markers of Hepatocytes and P21 Is Involved in Development of Pediatric Liver Cancer.
Rivas M; Johnston ME; Gulati R; Kumbaji M; Margues Aguiar TF; Timchenko L; Krepischi A; Shin S; Bondoc A; Tiao G; Geller J; Timchenko N
Cell Mol Gastroenterol Hepatol; 2021; 12(5):1669-1682. PubMed ID: 34245919
[TBL] [Abstract][Full Text] [Related]
2. C/EBPα-dependent preneoplastic tumor foci are the origin of hepatocellular carcinoma and aggressive pediatric liver cancer.
Cast A; Valanejad L; Wright M; Nguyen P; Gupta A; Zhu L; Shin S; Timchenko N
Hepatology; 2018 May; 67(5):1857-1871. PubMed ID: 29159818
[TBL] [Abstract][Full Text] [Related]
3. HDAC1 cooperates with C/EBPalpha in the inhibition of liver proliferation in old mice.
Wang GL; Salisbury E; Shi X; Timchenko L; Medrano EE; Timchenko NA
J Biol Chem; 2008 Sep; 283(38):26169-78. PubMed ID: 18622015
[TBL] [Abstract][Full Text] [Related]
4. Farnesoid X receptor inhibits gankyrin in mouse livers and prevents development of liver cancer.
Jiang Y; Iakova P; Jin J; Sullivan E; Sharin V; Hong IH; Anakk S; Mayor A; Darlington G; Finegold M; Moore D; Timchenko NA
Hepatology; 2013 Mar; 57(3):1098-106. PubMed ID: 23172628
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional and translational regulation of C/EBPβ-HDAC1 protein complexes controls different levels of p53, SIRT1, and PGC1α proteins at the early and late stages of liver cancer.
Jin J; Iakova P; Jiang Y; Lewis K; Sullivan E; Jawanmardi N; Donehower L; Timchenko L; Timchenko NA
J Biol Chem; 2013 May; 288(20):14451-14462. PubMed ID: 23564453
[TBL] [Abstract][Full Text] [Related]
6. C/EBPα inhibits hepatocellular carcinoma by reducing Notch3/Hes1/p27 cascades.
Shi YC; Zhao H; Yin C; Zeng X; Zhang Q; Xu WP; Wei J; Chen F; Xie WF
Dig Liver Dis; 2013 Oct; 45(10):844-51. PubMed ID: 23816696
[TBL] [Abstract][Full Text] [Related]
7. A positive regulatory domain in CCAAT/enhancer binding protein β (C/EBPΒ) is required for the glucocorticoid-mediated displacement of histone deacetylase 1 (HDAC1) from the C/ebpα promoter and maximum adipogenesis.
Abdou HS; Atlas E; Haché RJ
Endocrinology; 2013 Apr; 154(4):1454-64. PubMed ID: 23456364
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor (IGF)-II regulates CCAAT/enhancer binding protein alpha expression via phosphatidyl-inositol 3 kinase in human hepatoblastoma cell lines.
Tomizawa M; Saisho H
J Cell Biochem; 2007 Sep; 102(1):161-70. PubMed ID: 17372916
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic changes play critical role in age-associated dysfunctions of the liver.
Jin J; Wang GL; Iakova P; Shi X; Haefliger S; Finegold M; Timchenko NA
Aging Cell; 2010 Oct; 9(5):895-910. PubMed ID: 20698834
[TBL] [Abstract][Full Text] [Related]
10. C/EBPα alleviates hepatic ischemia-reperfusion injury by inhibiting endoplasmic reticulum stress via HDAC1-mediated deacetylation of ATF4.
Li R; Yang L; Li S; Chen S; Ren Y; Shen L; Dong L; Chen X; Li J; Xu M
J Biochem Mol Toxicol; 2024 Jan; 38(1):e23630. PubMed ID: 38229308
[TBL] [Abstract][Full Text] [Related]
11. Age-associated change of C/EBP family proteins causes severe liver injury and acceleration of liver proliferation after CCl4 treatments.
Hong IH; Lewis K; Iakova P; Jin J; Sullivan E; Jawanmardi N; Timchenko L; Timchenko N
J Biol Chem; 2014 Jan; 289(2):1106-18. PubMed ID: 24273171
[TBL] [Abstract][Full Text] [Related]
12. FXR-Gankyrin axis is involved in development of pediatric liver cancer.
Valanejad L; Lewis K; Wright M; Jiang Y; D'Souza A; Karns R; Sheridan R; Gupta A; Bove K; Witte D; Geller J; Tiao G; Nelson DL; Timchenko L; Timchenko N
Carcinogenesis; 2017 Jul; 38(7):738-747. PubMed ID: 28535186
[TBL] [Abstract][Full Text] [Related]
13. Cooperation of C/EBP family proteins and chromatin remodeling proteins is essential for termination of liver regeneration.
Jin J; Hong IH; Lewis K; Iakova P; Breaux M; Jiang Y; Sullivan E; Jawanmardi N; Timchenko L; Timchenko NA
Hepatology; 2015 Jan; 61(1):315-25. PubMed ID: 25043739
[TBL] [Abstract][Full Text] [Related]
14. HDAC1 promotes liver proliferation in young mice via interactions with C/EBPbeta.
Wang GL; Salisbury E; Shi X; Timchenko L; Medrano EE; Timchenko NA
J Biol Chem; 2008 Sep; 283(38):26179-87. PubMed ID: 18622014
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of histone deacetylase 1 (HDAC1) but not HDAC2 is required for the glucocorticoid-dependent CCAAT/enhancer-binding protein α (C/EBPα) expression and preadipocyte differentiation.
Kuzmochka C; Abdou HS; Haché RJ; Atlas E
Endocrinology; 2014 Dec; 155(12):4762-73. PubMed ID: 25203139
[TBL] [Abstract][Full Text] [Related]
16. Hdac1 Regulates Differentiation of Bipotent Liver Progenitor Cells During Regeneration via Sox9b and Cdk8.
Ko S; Russell JO; Tian J; Gao C; Kobayashi M; Feng R; Yuan X; Shao C; Ding H; Poddar M; Singh S; Locker J; Weng HL; Monga SP; Shin D
Gastroenterology; 2019 Jan; 156(1):187-202.e14. PubMed ID: 30267710
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic regulation and molecular characterization of C/EBPalpha in pancreatic cancer cells.
Kumagai T; Akagi T; Desmond JC; Kawamata N; Gery S; Imai Y; Song JH; Gui D; Said J; Koeffler HP
Int J Cancer; 2009 Feb; 124(4):827-33. PubMed ID: 19035457
[TBL] [Abstract][Full Text] [Related]
18. [DNA hypermethylation at C/EBPα gene promoter relieves a PPARγ-associated repression of HDAC1].
Zhao Q; Zhang Z; Li J; Zhang A
Zhonghua Yi Xue Za Zhi; 2014 Jan; 94(3):227-31. PubMed ID: 24731470
[TBL] [Abstract][Full Text] [Related]
19. HDAC1 inactivation induces mitotic defect and caspase-independent autophagic cell death in liver cancer.
Xie HJ; Noh JH; Kim JK; Jung KH; Eun JW; Bae HJ; Kim MG; Chang YG; Lee JY; Park H; Nam SW
PLoS One; 2012; 7(4):e34265. PubMed ID: 22496786
[TBL] [Abstract][Full Text] [Related]
20. PPARγ forms a bridge between DNA methylation and histone acetylation at the C/EBPα gene promoter to regulate the balance between osteogenesis and adipogenesis of bone marrow stromal cells.
Zhao QH; Wang SG; Liu SX; Li JP; Zhang YX; Sun ZY; Fan QM; Tian JW
FEBS J; 2013 Nov; 280(22):5801-14. PubMed ID: 23981481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
